Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Avid Bioservices Enters Manufacturing Agreement with Humanigen for Lenzilumab

February 04, 2021

The CGMP manufacturing agreement will expand production of lenzilumab, a candidate for COVID-19 therapy, to support a potential emergency use authorization filing.

PathoQuest Joins CAACB Consortium as Viral Safety Expert

February 04, 2021

PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.

Toxicology: Ensuring Drugs are Safe for People

February 02, 2021

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.

Protein Characterization Can Support Regulatory Submission

February 02, 2021

Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.

Delivering a Wealth of Expertise

February 02, 2021

Outsourcing partners can provide a multitude of advantages in the development of drug delivery solutions, including those designed for targeted patient populations.

Equipment Suppliers and CDMOs Advance Process Development

February 02, 2021

Collaboration between equipment suppliers and users is leading to innovation and optimization in biopharmaceutical manufacturing.

Best Practices for Designing and Building a Pharmaceutical Manufacturing Facility

February 02, 2021

For drug sponsors that are considering building their own manufacturing facilities, an expert project team is crucial.

Meeting Fill/Finish Challenges for COVID-19 Vaccines

February 02, 2021

CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.

Nexelis Expands Bioanalytical Services with Bioanalytical Lab Acquisition

February 01, 2021

Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.

Almac Invests in Expanding Global Biologics Testing Solutions

February 01, 2021

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.